Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure

Part of paid clinical trials in Farmington, Connecticut.

Sponsor
UConn Health
Study ID
NCT00762008
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The purpose of this research is to determine if two proteins in the blood are increased during acute heart failure. These two proteins are produced when the heart becomes dysfunctional and unable to contract normally. They may then be released into the blood and be detected by standard method in the research laboratory. Thus, the purpose of this study is to determine the relation between the change of these two proteins in the blood and the occurrence of acute heart failure. At this time, detection of an increase in these proteins in the blood is not known to be associated with any disease or heart failure.

Key Dates

Start date
Dec 31, 2005
Status verified
Jul 2025
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
500 participants (estimated)

Arms

  • Arm: Heart Failure

Primary Outcome Measure

Hospitalization for acute heart failure, myocardial infarction, stroke or death. [ Time Frame: 3 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Connecticut Health CenterFarmingtonConnecticut06030-

Find similar trials in Farmington, CT

By condition
Heart failure
By specialty
CardiologyHeart disease
By research site
University of Connecticut Health Center· Farmington, CT

Related Studies